Augmentation of Clozapine with Amisulpride: A Promising Therapeutic Approach to Refractory Schizophrenic Symptoms

References

• 1 Agelink M W, Kavuk I, Ak I. Clozapine combined with amisulpride for refractory schizophrenia: a retrospective analysis of 7 cases. Am J Psychiatry 2004; in press
• 2 Kämpf P, Agelink M W, Maß R, Jahn H, Schäfer I, Naber D. Amisulpride in addition to clozapine: a retrospective study indicates improved efficacy an good tolerability.  German J Psychiatry. 2003;  6 64-68
• 3 Martinot J L, Paillere-Martinot M L, Poirier M F, Dao-Castellana M H, Loch C, Maziere B. In vivo characteristics of dopamine D₂ receptor occupancy by amisulpride in schizophrenia.  Psychopharmacology. 1996;  124 154-158
• 4 Matthiasson P, Costa D C, Erlandsson K, Waddington W, Visvikis D, Cullum I, Cobb A M, Ell P J, Kerwin R W, Travis M J. The relationship between dopamine D2 receptor occupancy and clinical response in amisulpride augmentation of clozapine non-response.  J Psychopharmacol. 2000;  14 (3, Suppl.) A57 (Abs.PG19)
• 5 Nordstrom A L, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. D₁, D₂, and 5-HT₂ receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.  Am J Psychiatry. 1995;  152 1444-1449
• 6 Zink M, Knopf U, Henn F A, Thome J. Combination of clozapine and amisulpride in treatment-resistent schizophrenia - case reports and review of the literature.  Pharmacopsychiatry. 2004;  37 26-31